- Testing and waiving strategies for biocidal products and active substances
- Assessment of endocrine-disrupting properties according to Regulation 2017/2000 (ECHA/EFSA Guidance Document)
- Public literature search and evaluation
- Dossier compilation in IUCLID6
- Study management and monitoring for testing in toxicology, metabolism, dermal absorption and human exposure
- Classification and labelling of products and active substances
- Identification and assessment of "Substances of Concern"
- Exposure and risk assessment for biocidal products
